Long-term metformin use is associated with decreased risk of breast cancer.

There was, however, a tendency toward an increased relative breast cancer risks for long-term users (≥10 prescriptions) of thiazolidinediones, but the finding did not reach statistical significance.

also in 111,027 other papers